StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Regeneron Pharma (REGN) PT Raised to $600 at Baird on Strong Eylea Data
July 23, 2020 6:53 AM
Baird analyst Brian Skorney raised the price target on Regeneron Pharma (NASDAQ: REGN) to $600.00 (from $510.00) after procuring a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
